Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 399 for your search:
Drug:
carboplatin
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase:
Phase IV, Phase III
Type:
Treatment
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
GPOH-NB2004
, EU-20661, NCT00410631
2.
Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
XYL014
, NCT00708812
3.
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Phase:
Phase IV
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
MC#08-002
, IIT 12230, NCT00883675
4.
Phase II/III Study of Standard and Novel Conditioning Therapy Followed By Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia or Hematologic Malignancy
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
4 to 70
Sponsor:
Other
Protocol IDs:
RPCI-RP-9815
, NCI-V99-1527, NCT00003816, RP 98-15
5.
Phase II/III Randomized Study of Carboplatin and Ifosfamide With or Without Whole Body Hyperthermia in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Extraovarian Peritoneal Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
LMU-DOLPHIN-1
, EU-20220, NCT00045461
6.
Phase II/III Randomized Pilot Study of the Timing of Surgery and Chemotherapy in Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
Adult
Sponsor:
Other
Protocol IDs:
RCOG-MRC-CHORUS
, EU-20350, ISRCTN74802813, NCT00075712
7.
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
Haema CBF SCLC UK/AS 01
, NCT00168896
8.
Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 59
Sponsor:
Other
Protocol IDs:
N06IAA
, NCT00448266
9.
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
OXC4T4-302
, NCT00507429
10.
Phase II/III Study of Disease-Specific High-Dose Conditioning Regimens Followed by Autologous Stem Cell Transplantation (Single or Tandem) in Patients With Hematologic Malignancies or Solid Tumors
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
4 and over
Sponsor:
NCI
Protocol IDs:
RPCI-I-72806
, I 72806, NCT00536601
11.
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
Phase:
Phase III, Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2006-0374
, NCT00539500
12.
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
0 to 30
Sponsor:
Other
Protocol IDs:
EUDRACT 2005-002618-40
, BfArM-4030755, EC-105/05, DKS 2006.01, NCT00749723
13.
Phase II/III Randomized Study of Intravenous Paclitaxel and Carboplatin Versus Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Cisplatin Versus Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Stage IIB-III or Stage IV (With Only Pleural Effusion) Ovarian Epithelial, Primary Serous Type Peritoneal, or Fallopian Tube Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CAN-NCIC-OV21
, OV.21, UCL08/0379, GEICO-0902, NCT00993655
14.
Phase II/III Randomized Study of Concurrent Cisplatin and Radiotherapy With Versus Without Induction Chemotherapy Comprising Gemcitabine Hydrochloride, Carboplatin, and Paclitaxel in Patients With Locally Advanced Nasopharyngeal Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
SINGAPORE-NCC0901
, NCC0901, NCT00997906
15.
Phase III Randomized Study of Induction Chemotherapy With or Without Filgrastim (G-CSF) Followed By Surgery, Myeloablative Therapy, and Radiotherapy With Isotretinoin With or Without Monoclonal Antibody Ch14.18 in Patients With High-Risk Neuroblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 20 at diagnosis
Sponsor:
Other
Protocol IDs:
SIOP-EUROPE-HR-NBL-1
, ESIOP, EU-20148, NCT00030719
16.
Phase III Partially Randomized Study of Neoadjuvant Chemotherapy Followed By Surgery and Adjuvant Chemotherapy in Children With Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
SIOP-WT-2001
, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
17.
Phase III Study of Systemic Chemotherapy Comprising Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Pediatric Patients With Group C or D Intraocular Retinoblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
NCI
Protocol IDs:
COG-ARET0231
, ARET0231, NCT00072384
18.
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
DUMC03
, DUKE UNIVERSITY MEDICAL CENTER, CLINICAL STUDY PROTOCOL, NCT00090610
19.
Phase III Randomized Study of Induction Chemotherapy Comprising Docetaxel, Cisplatin, and Fluorouracil Followed By Radiotherapy and Carboplatin or Docetaxel Versus Radiotherapy and Cisplatin Only in Patients With Previously Untreated Stage III or IV Squamous Cell Carcinoma of the Head and Neck (Paradigm Trial)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
DFCI-04006
, AVENTIS-DFCI-04006, NCT00095875, PARADIGM TRIAL
20.
Phase III Randomized Study of Gemcitabine in Combination With Cisplatin Versus Carboplatin in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CRUK-BTOG2-LU3005
, EU-20510, NCT00112710
21.
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
11718
, NCT00111007
22.
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
71 and over
Sponsor:
Other
Protocol IDs:
JCOG0301
, C000000059, NCT00132665
23.
Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
119 of 2003
, NCT00193739
24.
Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
TROG 05.01
, NCT00193895
25.
Phase III Study of Observation and/or Chemotherapy Comprising Etoposide, Carboplatin, and Bleomycin With or Without Vinblastine, Ifosfamide, and Cisplatin After Surgical Resection or Biopsy in Pediatric Patients With Extracranial Malignant Germ Cell Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
CCLG-GC-2005-04
, EUDRACT-2004-002503-33, EU-20584, NCT00274950
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
